Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Devangelio

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Lupus|October 13, 2005
Thiazolidinediones and inflammationA Consoli, E Devangelio
Journal of Endocrinological Investigation|September 14, 2019
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world studyG P Fadini, P Li Volsi, E Devangelio, et al.
Diabetes & Metabolism|February 27, 2007
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjectsG Derosa, A D'Angelo, C Tinelli, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Lupus|October 13, 2005
Thiazolidinediones and inflammationA Consoli, E Devangelio
Journal of Endocrinological Investigation|September 14, 2019
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world studyG P Fadini, P Li Volsi, E Devangelio, et al.
Diabetes & Metabolism|February 27, 2007
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjectsG Derosa, A D'Angelo, C Tinelli, et al.
Pageof 1